ストックスクリーナーアプリを入手
0.3906
7.22%
0.0263
アフターアワーズ：
.38
-0.0106
-2.71%
前日終値:
$0.3643
開ける：
$0.39
24時間の取引高:
1.49M
Relative Volume:
1.38
時価総額：
$35.64M
収益：
$9.53M
当期純損益:
$-44.61M
株価収益率:
-0.4292
EPS:
-0.91
ネットキャッシュフロー:
$-38.32M
1週間 パフォーマンス:
+30.68%
1か月 パフォーマンス:
+20.26%
6か月 パフォーマンス:
-55.76%
1年 パフォーマンス:
-71.70%
1日の値動き範囲:
$0.3525
$0.3985
1週間の範囲:
$0.2834
$0.4595
52週間の値動き範囲:
$0.2302
$1.54
Cue Biopharma Inc Stock (CUE) Company Profile
CUE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CUE
Cue Biopharma Inc
|
0.3906 | 33.24M | 9.53M | -44.61M | -38.32M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-13 | 開始されました | Jefferies | Buy |
| 2023-06-26 | 再開されました | Oppenheimer | Outperform |
| 2022-11-21 | 開始されました | Piper Sandler | Overweight |
| 2022-01-13 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-03 | 開始されました | Craig Hallum | Buy |
| 2020-11-24 | 開始されました | Berenberg | Buy |
| 2020-04-09 | 開始されました | Stifel | Buy |
| 2020-01-28 | 開始されました | BTIG Research | Buy |
| 2020-01-22 | 開始されました | JMP Securities | Mkt Outperform |
すべてを表示
Cue Biopharma Inc (CUE) 最新ニュース
Volatility Watch: Is Cue Biopharma Inc forming a bullish divergence2025 Price Targets & Weekly High Potential Stock Alerts - baoquankhu1.vn
CUE Stock Price, Forecast & Analysis | CUE BIOPHARMA INC (NASDAQ:CUE) - Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Biotech Stocks Surge After Hours: IO Biotech Jumps 19%, Cue Biopharma And Cabaletta Bio Follow - Nasdaq
Is Cue Biopharma Inc. (1UC) stock overpriced at current multiples2025 Trading Volume Trends & Growth Oriented Trading Recommendations - bollywoodhelpline.com
Is Cue Biopharma Inc benefiting from interest rate changesInsider Buying & Daily Stock Momentum Reports - baoquankhu1.vn
Cue Biopharma (NASDAQ:CUE) Shares Up 9% – Should You Buy? - Defense World
Activity Recap: Whats the profit margin of Cue Biopharma IncJuly 2025 Short Interest & Low Drawdown Momentum Ideas - baoquankhu1.vn
Analyst Upgrade: Can Cue Biopharma Inc be recession proofJuly 2025 Snapshot & Daily Growth Stock Investment Tips - baoquankhu1.vn
Cue Biopharma launches proposed public offering of shares and warrants - MSN
Can Cue Biopharma Inc. stock outperform in 2025 bull marketWeekly Investment Recap & AI Driven Price Forecasts - Улправда
How sustainable is Cue Biopharma Inc. stock dividend payout2025 Growth vs Value & Short-Term Trading Alerts - Улправда
Why Cue Biopharma Inc. stock is trending among retail tradersStock Surge & Verified Momentum Stock Ideas - Улправда
What sentiment indicators say about Cue Biopharma Inc. stock2025 Pullback Review & Reliable Momentum Entry Alerts - Улправда
Aug Big Picture: Why Cue Biopharma Inc. stock remains resilient2025 Top Gainers & Consistent Return Strategy Ideas - Улправда
Why Cue Biopharma Inc. stock remains resilientJuly 2025 Highlights & Free Safe Capital Growth Stock Tips - Улправда
Will Cue Biopharma Inc. stock see insider buyingStop Loss Placement Tips & Small Entry Cost Investments - Улправда
Institution Moves: Will Cue Biopharma Inc 1UC stock benefit from mergersTrade Risk Assessment & AI Forecast Swing Trade Picks - Bộ Nội Vụ
Is Cue Biopharma Inc. stock attractive for growth ETFs2026 world cup usa national team semifinals top scorers high defensive line tactical prediction expert opinion - Улправда
2026 world cup lineups insights: Will Cue Biopharma Inc. stock benefit from AI adoption2026 world cup usa national team round of 32 young talents transition play tactical prediction insights - ulpravda.ru
EBIT per share of Cue Biopharma, Inc. – SWB:1UC - TradingView — Track All Markets
CUE Insider Trading - Quiver Quantitative
Is Cue Biopharma Inc a good long term investmentStock Screening Results & Big Gains Low Budget - earlytimes.in
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Cue Biopharma stock: niche immunotherapy bet caught in a bruising small-cap biotech storm - AD HOC NEWS
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Cue Biopharma (CUE) price target increased by 25.00% to 5.10 - MSN
Working capital per share of Cue Biopharma, Inc. – SWB:1UC - TradingView — Track All Markets
Cue Biopharma prices $10M underwritten public offering; shares down - MSN
Can Cue Biopharma Inc. stock rebound after recent weaknessTreasury Yields & Verified Swing Trading Watchlists - Улправда
How Cue Biopharma Inc. (1UC) stock reacts to stronger dollarMarket Activity Report & Risk Controlled Swing Trade Alerts - Улправда
Published on: 2025-12-20 23:54:48 - moha.gov.vn
Cue Biopharma Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Cue Biopharma Signs Underwriting Agreement With H.C. Wainwright & Co. - TradingView — Track All Markets
Cue Biopharma prices $10 million public offering at $0.28 per share - Investing.com Nigeria
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Cue Biopharma (CUE) Launches $10 Million Public Offering with Wa - GuruFocus
Cue Biopharma prices 35.7M shares at 28c in underwritten public offering - TipRanks
Cue Biopharma (CUE) Launches $10 Million Public Offering with Warrants - GuruFocus
Cue Biopharma announces pricing of $10 million public offering - marketscreener.com
Why retail investors pile into Cue Biopharma Inc. stock2025 Valuation Update & Safe Capital Growth Plans - ulpravda.ru
Cue Biopharma Announces Pricing of $10 Million Public Offering - GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Is Cue Biopharma Inc. (1UC) stock undervalued by metricsPortfolio Risk Report & Precise Trade Entry Recommendations - DonanımHaber
Why Cue Biopharma Inc. stock is seen as undervalued2025 Buyback Activity & Fast Gaining Stock Strategy Reports - DonanımHaber
How interest rate cuts could boost Cue Biopharma Inc. stockQuarterly Performance Summary & Daily Technical Stock Forecast Reports - DonanımHaber
Cue Biopharma launches public offering of common stock and warrants By Investing.com - Investing.com Australia
Insider Trends: Why retail investors pile into Cue Biopharma Inc. stockAnalyst Downgrade & Free High Accuracy Swing Entry Alerts - Улправда
Will Cue Biopharma Inc. stock benefit from AI adoptionQuarterly Growth Report & Free Fast Entry Momentum Trade Alerts - Улправда
Cue Biopharma (CUE) Announces Proposed Offering with Key Managers - GuruFocus
Cue Biopharma stock tumbles on public offering announcement By Investing.com - Investing.com Canada
Cue Biopharma Inc (CUE) 財務データ
収益
当期純利益
現金流量
EPS
2.09%
0.48%
大文字化:
|
ボリューム (24 時間):